Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCatenai Plc Regulatory News (CTAI)

Share Price Information for Catenai Plc (CTAI)

Share Price is delayed by 15 minutes
Get Live Data
0.175    0.00 (0.00%)
Bid:
0.16
Ask:
0.19
Spread: 0.03 (18.75%)
Market Cap: £2.51m
CTAI Live PriceLast checked at - London Stock Exchange

Intraday Catenai Plc Share Chart

Final Results

30 Jun 2026 16:15

RNS Number : 4528K
Catenai PLC
30 June 2026
 

Catenai PLC

 

("Catenai", the "Company")

 

Final Results

 

Catenai PLC (AIM: CTAI), the AIM quoted provider of digital media and technology services, announces its full year audited results for the year ended 31 December 2025.

 

Financial overview

· The Company made a net loss for the year of £496,401 (2024: £128,714). Revenues for the year were £71,350 (2024: £131,500).

· The Company has a statement of financial position at the year-end showing net assets of £2,462,040 (2024 net assets: £404,568).

Operational overview

· The Company raised significant funds in the year and was able to continue to support Klarian Ltd as well as make a new investment into Alludium Ltd.

· The Board are pleased with the progress of both Klarian and Alludium. The Board looks forward to further progress in the near term.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The person who arranged for release of this announcement on behalf of the Company was John Farthing, Interim Chief Executive Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

 

For further information please contact:

 

Catenai PLC

+44 (0)20 7183 8666

John Farthing, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Ludovico Lazzaretti / James Western

Shard Capital Partners LLP (Broker)

+44 (0)20 7186 9952

Damon Heath

Yellow Jersey PR

+44 (0) 20 3004 9512

Charles Goodwin / Ryan Forecast

 

Notes to Editors:

 

About Catenai PLC

Catenai is an AIM quoted provider of digital media and technology services. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

www.catenaiplc.com

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

 

Chairman's Statement

 

Business and performance review

 

The Company raised significant funds in the year and was able to continue to support Klarian Ltd as well as make a new investment into Alludium Ltd.

 

We are pleased with the progress of both Klarian and Alludium. We look forward to further progress in the near term.

 

The BTC Treasury is under review and to date no purchases of BTC have been made.

Board changes

 

There were no changes during the year.

 

Financial overview

 

The Company made a net loss for the year of £496,401 (2024: £128,714). Revenues for the year were £71,350 (2024: £131,500).

 

The Company has a statement of financial position at the year-end showing net assets of £2,462,040 (2024 net assets: £404,568).

 

Working capital and fund raisings

 

During the year, the Company raised £2,521,404 through a combination of placings, subscriptions and settlement of liabilities by the issue of shares.

Company strategy

 

The Board continues to focus on organic growth, building on existing customer relationships and attracting new clients, and on identifying and exploring strategic acquisitions to build the Company and improve shareholder value.

 

Operational KPIs

These are:

● number of customers;

● number of repeat orders;

● number of acquisition opportunities reviewed; and

● bank balance.

 

Current Trading and Outlook

We continue to seek additional work from customers and develop the relationship with Alludium Ltd. The recent fundraise puts the Company in an excellent cash position.

 

I would like to thank the team at Catenai for their commitment and tenacity in pursuing every opportunity to bring new business into the Company.

 

 

 

Post period end

 

After the year end the Company invested a further £250,000 into Alludium Ltd. Please refer to note 22 for further details.

 

Since the start of 2026, Alludium has progressed from a horizontal, early-stage AI agent business into a customer-facing platform with a clear vertical focus. The company launched its platform to its initial design partners, has now delivered a significant V2 release, and refined its proposition around venture capital, where repeatable, high-context workflows are a clear initial use case for reliable AI execution with human oversight. Working closely with SVV (Sure Valley Ventures) as a design partner, Alludium has developed VC-focused workflows across areas such as sourcing, screening, diligence and internal review. Alludium has now moved from product development into active sales, with engagement underway across potential customers through outbound activity, inbound interest and warm introductions.

 

 

Brian Thompson

Chairman

29 June 2026

 

Statement of comprehensive income for the year ended 31 December 2025

 

 

 

 

31 December

31 December

 

2025

2024

£

£

Revenue

71,350

131,500

Cost of sales

-

-

Gross profit

71,350

131,500

Administrative expenses

 

Reversal of provision

 

 

 

(523,623)

 

-

(262,679)

 

-

Loss from operations

(452,273)

(131,179)

Interest expenses

(56,309)

(508,582)

Bank interest received

12,181

3,005

Loss before taxation

(496,401)

(128,174)

Taxation credit

-

-

Loss from continuing operations

(496,401)

(128,174)

 

Total comprehensive loss for the year

(496,401)

(128,174)

 

Basic and diluted loss per share (pence)

 

 

 

(0.05)

 

(0.04)

 

The notes form part of these financial statements.

Statement of financial position at 31 December 2025

 

 

 

 

 

 

 

 

 

2025

2024

 

£

£

 

Non-current assets

 

Intangible assets

1

1

 

Investments

950,000

-

 

950,001

1

 

Current assets

 

Trade and other receivables

988,493

578,321

 

Cash and other equivalents

586,446

477

 

1,574,939

578,798

 

Current liabilities

 

Trade and other payables

(50,400)

(174,230)

 

Loans and borrowings

(12,500)

-

 

(62,900)

(174,230)

 

Non current liabilities

 

 

 

Loans and borrowings

-

-

 

Total liabilities

(62,900)

(174,230)

 

 

 

 

Net assets / (liabilities)

2,462,040

404,568

 

 

Capital and reserves

 

Ordinary share capital

143,386

789,149

Deferred share capital

4,387,684

3,615,192

Share premium account

22,186,901

19,956,224

Share reserve

-

(83,333)

Share warrant

196,467

-

Merger reserve

11,119,585

11,119,585

Capital redemption reserve

2,732,904

2,732,904

Retained Losses

(38,304,887)

(37,725,153)

Shareholders' funds

2,462,040

404,568

The financial statements were approved by the Board and authorised for issue on 29 June 2026

 

Brian ThompsonChairman

The notes form part of these financial statements.

Statement of cash flows for the year ended 31 December 2025

 

 

 

 

 

 

 

31 December

31 December

Cash flow from operating activities

 

2025

2024

£

£

Loss for the year

(496,401)

(128,174)

Adjustments for:

Amortisation of intangible assets

-

-

Net bank and other interest charges

-

-

Services settled by the issue of shares

136,000

-

Issue of share options and warrants charge

168,468

-

Net cash outflow before changes in working capital

(191,933)

(128,174)

(Increase)/Decrease in trade and other receivables

353,423

(561,029)

(Decrease) / Increase in trade and other payables

101,386

15,295

Cash outflow from operations

454,809

(673,908)

Interest received

-

-

Interest paid

(56,309)

-

Net cash flows from operating activities

(56,309)

-

Investing activities

Investment in Alludium

(950,000)

-

Net cash flows from investing activities

(950,000)

-

Financing activities

Issue of share capital

1,493,400

720,000

Share issue costs

(163,998)

(46,800)

New loans raised

-

-

Net cash flows from financing activities

1,329,402

673,200

 

Net (decrease) / increase in cash

 

585,969

 

(708)

Cash and cash equivalents at beginning of year

477

1,185

 

Cash and cash equivalents at end of year

586,446

477

During the year the Company settled £1,028,004 (2024: £292,700) of liabilities by the issue of shares in non-cash transactions.

The notes form part of these financial statements.

Statement of changes in equity for the year ended 31 December 2025

 

 

 

Share Capital

 

Share Premium

Deferred Shares / Shares to be issued

 

Other Reserves

 

Retained Earnings

 

Total Equity

£

£

£

£

£

£

Balance at 31 Dec 2023

 

570,078

 

19,665,457

 

3,159,130

 

13,769,156

 

(37,596,979)

 

(433,158)

 

Loss for the year

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(128,174)

 

 

(128,174)

Share capital

Issued

 

 

219,071

 

290,767

 

456,062

 

 

 

 

965,900

 

Balance at 31 Dec 2024

 

 

789,149

 

19,956,224

 

3,615,192

 

13,769,156

 

(37,725,153)

 

404,568

Loss for the year

-

-

-

(496,401)

(496,401)

Share capital Issued

 

126,729

2,394,675

-

-

-

2,521,404

Sub-division of the share capital

(772,492)

-

772,492

-

-

-

Less issue cost

-

(163,998)

-

-

-

(163,998)

Share Warrant

-

-

-

196,467

-

196,467

Share option lapsed

-

-

-

83,333

(83,333)

-

Balance at 31 Dec 2025

143,386

22,186,901

4,387,684

14,048,956

(38,304,887)

2,462,040

 

 

The other reserves relate to the merger reserve, share reserve and the capital redemption reserve.

 

The notes form part of these financial statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FLFIERAIIVIR
12
Date   Source Headline
1st Jul 20268:00 amRNS-RAlludium Named Partner for AgenticInvestor
30th Jun 20264:15 pmRNSFinal Results
22nd May 20267:00 amRNSKlarian Update and Webinar
14th May 20267:00 amRNS-RAlludium VC Vertical Launch & Website Update
20th Apr 20267:00 amRNSContract Renewal and Klarian Update
2nd Apr 20267:00 amRNS-RAlludium Achieves Certifications
19th Mar 20267:00 amRNSAlludium secures first paying customers
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
19th Feb 20267:00 amRNS-RUpdate re Alludium
20th Jan 20267:00 amRNS-RNew Company Website
19th Jan 202612:32 pmRNSHolding(s) in Company
5th Jan 20267:00 amRNSKlarian update
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
11th Dec 20257:00 amRNS-RInvestor Presentation
1st Dec 20257:00 amRNS-RAlludium Update
11th Nov 20257:00 amRNS-RAlludium launches new website
4th Nov 20257:00 amRNSRepayment of Loan & Issue of Warrants
30th Oct 20257:00 amRNSAlludium Commercial Launch
30th Sep 20257:00 amRNSHalf-year Report
15th Sep 20257:00 amRNS-RSVV featuring Alludium in AI Webinar series
28th Jul 20257:00 amRNSUpdate on Treasury
17th Jul 20257:00 amRNSInvestment in Alludium
15th Jul 20253:15 pmRNSResult of GM & Issue of Equity
7th Jul 20257:00 amRNSAlludium “First Look” Event
1st Jul 20257:00 amRNSNotice of GM & Further Re Fundraise
30th Jun 20257:00 amRNSFinal Results & Klarian Update
26th Jun 20257:54 amRNSFundraise of up to £1.6m
16th Jun 20257:00 amRNS-RAlludium 'First Look' Investor Event in London
9th Jun 20257:00 amRNSAlludium Strategic Program Update
27th May 20257:00 amRNSAlludium accepted into NVIDIA Inception
21st May 20257:00 amRNSFurther re investment in Alludium, Issue of Equity
15th May 20257:30 amRNSLaunch of Alludium at LangChain’s AI Conference
13th May 20257:10 amRNSInvestment in Alludium
12th May 20251:23 pmRNSResult of AGM, Issue of Equity, Warrants
6th May 202510:37 amRNSProposed Issue of Warrants
30th Apr 20253:30 pmRNSInsurance Policy Renewal
29th Apr 20251:00 pmRNSExercise of Warrant
17th Apr 20253:34 pmRNSNotice of AGM & Proposed Share Sub-division
11th Apr 20257:00 amRNSProposed Investment in Alludium, Fundraise
8th Apr 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSKlarian update
25th Mar 20257:00 amRNSDirector Disclosure Update
17th Jan 202511:58 amRNSHolding(s) in Company
16th Jan 202510:27 amRNSHolding(s) in Company
14th Jan 202512:37 pmRNSWorking Capital Loan and Related Party Transaction
13th Jan 202510:39 amRNSKlarian CLN Update
29th Nov 20247:00 amRNSInsurance Policy Renewal & RPT
28th Oct 20247:00 amRNSKlarian update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.